Advertisement
Screener

Alto Neuroscience, Inc. (ANRO) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Alto Neuroscience, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Alto Neuroscience, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $51.77M went out.
  • Fiscal year ended 2025-12-31: from investing, $24.00K went out.
  • Fiscal year ended 2025-12-31: from financing, $60.08M came in.
  • Fiscal year ended 2025-12-31: change in cash, $8.26M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew shares soldNot split outChange in cash
2025-12-31-$51.77M-$24.00K-$10.21M$703.00K$69.59M*$8.26M
2024-12-31-$47.42M-$2.08M$0.00$187.00K$135.50M*$86.18M
2023-12-31-$33.45M-$470.00K$181.00K$67.95M*$34.20M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew debtStaff share taxNew shares soldNot split outChange in cash
2026-06-30-$19.76M*$0.00*$0.00*$0.00*$75.00K*
2026-03-31-$27.09M-$556.00K$0.00-$190.00K$6.00K$115.13M*$87.28M
2025-12-31-$11.52M*$0.00*$0.00*$352.00K*$49.83M*
2025-09-30-$9.92M*$0.00*$0.00*$153.00K*
2025-06-30-$13.78M*$0.00*$0.00*$0.00*$613.00K*
2025-03-31-$16.56M-$24.00K-$10.21M$19.69M$198.00K*-$7.47M
2024-12-31-$13.02M*-$506.00K*$0.00*$49.00K*
2024-09-30-$11.73M*-$1.00M*$0.00*$67.00K*$1.25M*
2024-06-30-$11.69M*-$340.00K*$0.00*$61.00K*
2024-03-31-$10.98M-$224.00K$0.00$0.00$10.00K$134.55M*$123.35M
2023-12-31-$11.52M*-$352.00K*$29.00K*$43.10M*
2023-09-30-$7.76M*-$43.00K*$109.00K*
2023-06-30-$6.63M*-$54.00K*$43.00K*
2023-03-31-$7.52M-$21.00K$0.00$25.00M*$17.44M

Similar stocks

Stock NameCountryMarket CapPE Ratio
MANNKIND CORP (MNKD)United States$1.058B-30.41
Savara Inc (SVRA)United States$1.044B-9.10
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
Amphastar Pharmaceuticals, Inc. (AMPH)United States$1.116B10.93
Seaport Therapeutics, Inc. (SPTX)United States$1.131B
Corvus Pharmaceuticals, Inc. (CRVS)United States$0.994B-23.25
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Arbutus Biopharma Corp (ABUS)$0.965B6.19